A review of the safety of favipiravir – a potential treatment in the COVID-19 pandemic?

BACKGROUND: Repurposing broad-spectrum antivirals is an immediate treatment opportunity for 2019 coronavirus disease (COVID-19). Favipiravir is an antiviral previously indicated for influenza and Ebola, which has shown some promise in early trials for treatment of COVID-19. We aim to review existing...

Descripción completa

Detalles Bibliográficos
Autores principales: Pilkington, Victoria, Pepperrell, Toby, Hill, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mediscript Ltd 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331506/
https://www.ncbi.nlm.nih.gov/pubmed/32405421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331506/
https://www.ncbi.nlm.nih.gov/pubmed/32405421

Ejemplares similares